PP2A
Overview
Protein Phosphatase 2A (PP2A) is a highly conserved serine/threonine phosphatase and one of the most abundant protein phosphatases in mammalian cells, comprising approximately 0.5-1% of total cellular protein. As a member of the phosphoprotein phosphatase (PPP) superfamily, PP2A functions as a critical negative regulator of protein phosphorylation events across diverse cellular processes. The enzyme exists as a multi-subunit complex with remarkable structural flexibility, allowing it to regulate hundreds of substrate proteins and participate in numerous signaling cascades relevant to neuronal homeostasis and degeneration.
Function/Biology
PP2A operates as a catalytic core enzyme that requires association with regulatory subunits to achieve substrate specificity and cellular localization. The canonical PP2A holoenzyme consists of three major components: the catalytic subunit (PP2Ac), the scaffolding A subunit (PP2A-A), and a variable regulatory B subunit. The B subunit family comprises multiple isoforms (B, B', B'', and B''') that determine substrate recognition and subcellular localization. This modular architecture enables PP2A to form distinct phosphatase complexes tailored for specific cellular compartments and signaling contexts.
...PP2A
Overview
Protein Phosphatase 2A (PP2A) is a highly conserved serine/threonine phosphatase and one of the most abundant protein phosphatases in mammalian cells, comprising approximately 0.5-1% of total cellular protein. As a member of the phosphoprotein phosphatase (PPP) superfamily, PP2A functions as a critical negative regulator of protein phosphorylation events across diverse cellular processes. The enzyme exists as a multi-subunit complex with remarkable structural flexibility, allowing it to regulate hundreds of substrate proteins and participate in numerous signaling cascades relevant to neuronal homeostasis and degeneration.
Function/Biology
PP2A operates as a catalytic core enzyme that requires association with regulatory subunits to achieve substrate specificity and cellular localization. The canonical PP2A holoenzyme consists of three major components: the catalytic subunit (PP2Ac), the scaffolding A subunit (PP2A-A), and a variable regulatory B subunit. The B subunit family comprises multiple isoforms (B, B', B'', and B''') that determine substrate recognition and subcellular localization. This modular architecture enables PP2A to form distinct phosphatase complexes tailored for specific cellular compartments and signaling contexts.
The catalytic mechanism of PP2A involves metal-dependent dephosphorylation, utilizing two metal ions (typically manganese and iron) within the active site to facilitate hydrolysis of phosphoester bonds. The enzyme demonstrates broad substrate specificity, including protein kinases, transcription factors, signaling proteins, and cytoskeletal elements. PP2A activity is regulated through multiple mechanisms including methylation of the catalytic subunit, phosphorylation of regulatory subunits, endogenous inhibitor proteins (PME-1, SET/I2PP2A), and subcellular sequestration.
Role in Neurodegeneration
PP2A dysfunction emerges as a consistent feature across multiple neurodegenerative diseases, suggesting it represents a convergent pathogenic mechanism. In Alzheimer's disease, reduced PP2A activity correlates with hyperphosphorylation of tau protein, a hallmark pathological feature. PP2A acts as the primary physiological tau phosphatase; its diminished activity allows abnormal tau accumulation and aggregation. Additionally, PP2A regulates amyloid precursor protein (APP) metabolism and the activity of kinases that promote amyloid-beta generation.
In Parkinson's disease and related alpha-synucleinopathies, PP2A participates in regulating alpha-synuclein phosphorylation and protein kinase pathways implicated in neurodegeneration. Altered PP2A expression and localization have been documented in Parkinson's disease brains. In Huntington's disease, PP2A dysfunction contributes to defective handling of mutant huntingtin protein and impaired cellular quality control mechanisms.
The enzyme also regulates critical survival pathways; reduced PP2A activity impairs the protein kinase B (AKT)/GSK3β signaling axis that promotes neuronal survival and inhibits tau hyperphosphorylation. Furthermore, PP2A controls the balance between pro-survival and pro-apoptotic signaling, influencing whether neurons activate protective mechanisms or undergo cell death.
Molecular Mechanisms
PP2A-mediated neurodegeneration involves both loss-of-function and dysregulation mechanisms. Oxidative stress and protein modifications in neurodegenerative disease environments inactivate PP2A catalytic subunits through oxidation of critical methionine residues and excessive dephosphorylation by PME-1. Chronic inhibition of PP2A activity perpetuates kinase hyperactivation, particularly of tau kinases (GSK3β, CDK5, ERK) that promote pathological protein phosphorylation.
PP2A dysfunction also impairs autophagy and proteasomal degradation pathways essential for clearing misfolded proteins. The phosphatase regulates mTOR signaling, which coordinates autophagy induction; reduced PP2A activity favors mTOR hyperactivation and autophagy suppression. Additionally, PP2A loss compromises the JNK/c-Jun pathway balance, promoting neuroinflammation and excitotoxicity.
Clinical/Research Significance
PP2A represents a promising therapeutic target given its central role in multiple neurodegenerative diseases. Strategies to enhance PP2A activity, including direct phosphatase activators and inhibitors of endogenous PP2A inhibitors (targeting SET/I2PP2A or PME-1), are under investigation. Restoring PP2A function could simultaneously address multiple pathogenic mechanisms across disease subtypes.
- Tau protein and tau kinases (GSK3β, CDK5)
- Protein Kinase B (AKT)
- Glycogen synthase kinase 3 beta (GSK3β)
- Alpha-synuclein
- Amyloid precursor protein (APP)
- PP2A inhibitors (PME-1, SET/I2PP2A)
- mTOR signaling pathway
- Autophagy regulation
- Protein phosphorylation cascades